Janet Yellen is 'completely disconnected' from everyday Americans: E.J. Antoni
Heritage Foundation public finance economist E.J. Antoni criticizes Treasury Secretary Janet Yellen's claim that the economy is on track for a 'soft landing' on 'Making Money.'
Apple Intelligence will be baked into all devices: Katie Linendoll
Consumer tech expert Katie Linendoll discusses Apple's new iPhone 16 on 'Cavuto: Coast to Coast.'
Investors are eying 'favorable' markets in Indonesia, Colombia, South Africa, Brazil: Rich Nuzum
Mercer Global chief investment strategist Rich Nuzum analyzes the end of a busy week in the European markets and which global sectors are most profitable.
Markets are 'certainly' in a correction period, so optimize diversification: Mark Newton
Fundstrat Global Advisors managing director Mark Newton argues the tech sector remains strong, while others struggle to meet bull market tops.
There are 'real challenges' ahead for Boeing, Google: Scott Ladner
Horizon Investments CIO Scott Ladner and Aquinas Wealth Advisors President Chris McMahon analyze the market's latest 'paradox' as well as Boeing and Alphabet stocks, respectively.
The 'bad part' of this economic policy is widening gap between middle, upper class: James Iuorio
TJM Institutional Services director James Iuorio cautions that there's more 'uncertainty' to hit markets amid the presidential election and the Federal Reserve's next rate decision.
Market correction of 10 to 15% would not be surprising: Phil Blancato
Osaic Inc. chief market strategist Phil Blancato analyzes the overall market as volatility persists on 'Making Money.'
Buy Nvidia between $95 and $104: D.R. Barton
Woodshaw Financial Group principal D.R. Barton analyzes Nvidia and reveals what defense stocks he's buying on 'Varney & Co.'
Nvidia volatility could continue until after the election: Rob Luna
Rob Luna Wealth Academy founder Rob Luna discusses what's behind Nvidia's stock plunge on 'Making Money.'
Tammy Bruce calls out anxious Gen Z worker: 'It's called growing up'
FOX Business correspondent Kelly O’Grady and Fox News contributor Tammy Bruce discuss the fiscal impact of immigration and generational differences in the workplace on 'Making Money.'
Piper Sandler's Michael Kantrowitz unveils 10 underappreciated market facts
Piper Sandler chief investment strategist Michael Kantrowitz explains how investors can make more informed market decisions on 'Making Money.'
No tax on tips is a net positive: Carl Sobocinski
Table 301 Restaurant Group President and owner Carl Sobocinski discusses Trump's 'no tax on tips' plan on 'Cavtuo: Coast to Coast.'
Stuart Varney: Harris' guiding light is not growth and prosperity, it's winning elections
'Varney & Co.' host Stuart Varney argues Kamala Harris is not interested in prosperity for America, only winning the election.
Nvidia antitrust probe creates an opportunity for investors: Michael Lee
Michael Lee Strategy founder Michael Lee discusses whether his Nvidia 'buy the dip' strategy has changed on 'Varney & Co.'
Housing and stocks are the greatest market risks right now: Jack Ablin
Cresset CIO and founding partner Jack Ablin discusses what it would take for the Fed to cut interest rates more than 25 basis points on 'Making Money.'
Demand for bonds likely to rise in the year ahead: Kelsey Berro
J.P. Morgan Asset Management fixed income portfolio manager Kelsey Berro discusses whether the Fed accomplished its inflation goal on 'Making Money.'
Economy is 'remarkably resilient' despite tighter monetary policy: Ed Yardeni
Yardeni Research President Ed Yardeni reveals what most economists are missing about the U.S. economy on 'Making Money.'
Intel has its 'work cut out' despite launch of new chips: Beth Kindig
I/O Fund lead tech analyst Beth Kindig discusses whether Intel will exit the Dow 30 after the release of its next-gen core ultra chips on 'Varney & Co.'
Apple Intelligence will 'wow' users: Kyle Wool
Dominari Financial CEO Kyle Wool discusses whether Apple will benefit from the A.I. craze on 'Varney & Co.'
Who's actually footing the bill for obesity drugs?
'Barron's Roundtable' panelists discuss questions remaining over obesity drug cost coverage and growing concerns over side effects.



















